Taxol treatment of breast cancer
US5496846A · kind A · utility
30Cited by
0References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 6, 1994 |
| Grant date | Mar 5, 1996 |
| Priority date | — |
| Expiry date | Jan 6, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is a method of treatment for a patient with cancer. In particular, it is a method of treating patients having breast cancer using the microtubule agent, Taxol. The present method of administration, serves to prevent or retard the adverse side effects associated with Taxol and reduces the chances of a patient developing mdr Taxol resistance. The novel method of treatment provides a low-dose, longterm exposure to Taxol in a patient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.